A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Beijing Biotech
Incyte Corporation
Servier
Sumitomo Pharma America, Inc.
Curis, Inc.
Dana-Farber Cancer Institute
Auron Therapeutics, Inc.
Senti Biosciences
NextCure, Inc.
Prelude Therapeutics
Peking University People's Hospital
Geron Corporation
Thomas Jefferson University
M.D. Anderson Cancer Center
Ryvu Therapeutics SA
Celgene
University of Illinois at Chicago
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Servier
M.D. Anderson Cancer Center